Calvatia gigantea CALVAKEHL D 4 Tablets

SANUM-KEHLBECK GmbH & Co. KG

Sale price £69.11 Regular price £90.00

Tax included. Shipping calculated at checkout.

CALVAKEHL D 4 Calvatia gigantea Tablets

CALVAKEHL D 4 Tablets benefits:

Calvakehl® D4 tablets are a registered homeopathic remedy containing Calvatia gigantea (giant puffball) at D4 potency, used to support overall wellness, though specific therapeutic indications are not officially approved. They are commonly used in holistic approaches for immune system support and to manage fungal issues. 
Key Aspects and Potential Benefits:
Active Ingredient: Each tablet contains 250 mg of Calvatia gigantea e sporibus D4 trit.
Supportive Remedy: As a homeopathic mushroom preparation, it is used to stimulate self-healing mechanisms.
Dosage: Typically, 1 tablet is taken 1–3 times daily with liquid.
Safety Profile: No known side effects or interactions are reported.
Caution: Contains lactose and should not be used in children under 12 or during pregnancy/breastfeeding without medical advice. 
It is recommended to consult a healthcare professional for guidance on specific, individualized uses.

Calvakehl D4 tablets. Indications: Registered homeopathic medicinal product, therefore without a stated therapeutic indication.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Calvakehl D4 Tablets
Homeopathic medicinal product
Active ingredient: Calvatia gigantea e sporibus Trit. D4

Dear Patient,
Please read this package leaflet carefully, as it contains important information about what you should consider when using this medicine. If you have any questions, please consult your doctor or pharmacist.

Indications:
Registered homeopathic medicinal product, therefore without a stated therapeutic indication. If symptoms persist during use of the medicine, medical advice should be sought.

Contraindications:
See Precautions and Warnings.

Precautions for use and warnings:
What should you consider during pregnancy and breastfeeding?
Since there is insufficient documented experience regarding its use during pregnancy and breastfeeding, this medicine should only be used after consulting a doctor.

What should be considered
when using this medicine in children? There is insufficient documented experience regarding the use of this medicine in children. Therefore, it should not be used in children under 12 years of age.

Interactions with other medicines:
None known. General information: The effect of a homeopathic medicine can be adversely affected by generally harmful lifestyle factors and by stimulants and other substances of abuse. If you are taking other medicines, consult your doctor.

Warning:
This medicine contains lactose. Therefore, please only take Calvakehl D4 after consulting your doctor if you know that you have an intolerance to certain sugars.

Dosage instructions, method and duration of use:
The following information applies unless your doctor has prescribed otherwise. Please adhere to the instructions for use, as this medicine may not work properly otherwise!

How long should you use Calvakehl D4?
Even homeopathic medicines should not be used for extended periods without medical advice.

Side effects:
None known. Note: When taking homeopathic medicines, existing symptoms may temporarily worsen (initial aggravation). In this case, you should stop taking the medicine and consult your doctor.

Reporting of side effects:
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Federal Institute for Drugs and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, Germany, website: www.bfarm.de. By reporting side effects, you can help provide more information on the safety of this medicine.

Information on the shelf life of the medicine:
The expiry date is printed on the container and outer packaging. Do not use this pack after this date!

Composition:
1 tablet contains the active ingredient: 250 mg Calvatia gigantea e sporibus Trit. D4 (HAB, Regulation 4a with ethanol 62% (w/w), Regulations 6 and 7 with lactose). Other ingredients: potato starch, magnesium stearate. Note for diabetics: 1 tablet contains less than 0.1 bread units (BU).

Dosage form and contents:
80 tablets or 240 tablets for oral use.

Marketing Authorisation Holder and Manufacturer:
Sanum-Kehlbeck GmbH & Co. KG, P.O.
Box 1355,
D-27316 Hoya, Germany.

Calvatia gigantea CALVAKEHL D 4 Tablets